Relyens Innovation Santé
Venture capital subsidiary (SCR) of Relyens (Relyens Mutual Insurance)
Also known as SHAM Innovation Santé, Sham Innovation Santé, RELYENS INNOVATION SANTE
Venture capital company (SCR) of mutual insurer Relyens, Lyon, set up in 2014 as Sham Innovation Santé; invests in e-health, medtech and biotech start-ups, advised by Turenne Santé.
- HEADQUARTERS
- Lyon, France
- FOUNDED
- 2014
- AUM
- —
- OUTSIDE CAPITAL
- No — own capital only
- TEAM LISTED
- 3 people
FOCUS
- STAGES
- SeedSeries A
- ASSET MIX
- Venture capital
- GEOGRAPHY
- France
WHAT IT IS
Corporate VC. A corporation investing from its own balance sheet, usually with strategic goals.
ABOUT
Relyens Innovation Santé, formerly SHAM Innovation Santé, is a société de capital-risque created in 2014 as a subsidiary of the European mutual insurance group Relyens, and advised by Turenne Groupe’s healthcare team (Turenne Santé) since May 2014. It invests in companies developing breakthrough technologies in e-health, medtech and biotech that address large unmet medical needs. In April 2026 the sale of PathoQuest to Charles River Laboratories was its tenth exit since launch. Relyens also invests in health innovation through The Techcare Company and commitments to several health-focused funds.
INVESTMENT THESIS
Minority investments in companies developing breakthrough medical technologies (biopharmaceutical platforms, medical devices, diagnostics, e-health) addressing large unmet medical needs, with a focus on projects that improve quality of care, efficiency and the economics of the health system.
PORTFOLIO (5)
- KimialysBiotech & Life Sciences · since 2025
- Ventuno BiotechBiotech & Life Sciences · since 2025
- PathoQuestBiotech & Life Sciences · Acquired
- DessinteyHealthTech · since 2019 · Exited
- PhysioAssistHealthTech · Acquired
TEAM
LINKS
FAQ
Relyens Innovation Santé is a corporate venture arm based in Lyon, France, founded in 2014.
Yes. Relyens Innovation Santé invests directly in private companies.
Relyens Innovation Santé invests at Seed and Series A stages in HealthTech and Biotech & Life Sciences.
Key people at Relyens Innovation Santé include Sandrine Pernette (Chief Investment Officer, Relyens (Directrice des investissements)), Mounia Chaoui (Deputy CEO, Turenne Santé (adviser)) and Claire Poulard (Investment Director, Turenne Santé (adviser)).
Relyens Innovation Santé's investments include Kimialys, Ventuno Biotech, PathoQuest, Dessintey and PhysioAssist.
The most recent publicly reported investment by Relyens Innovation Santé is Kimialys (€3.6M round (lead)), announced in Dec 2025.
No. Relyens Innovation Santé invests its own capital and does not raise money from outside investors.